MicroMass Recognized with Bronze Award
ZEJULA My Way Patient Support Program won bronze in the 2018 Pharma Choice Awards in the DTC/DTP category.
The ZEJULA My Way Patient Support RM program reinforces the empowered spirit of the I’ll Start Something patient campaign. The program uses an integrated, multichannel strategy to make resources, tools, and information accessible to patients whenever and however they need them throughout treatment.
The primary goal of the ZEJULA My Way Patient Support RM program is to enable women taking ZEJULA to stay on treatment as long as possible. This will be accomplished by helping each patient with recurrent ovarian cancer:
- Build skills to manage a daily routine that includes ZEJULA and any associated side effects
- Identify and address emotional needs, so she can stay positive, motivated, and move forward
- Address unmet psychosocial support-related needs (finding support groups, recruiting a care partner, and improving communication with her care team)
- Access support-related information, tools, and resources when and how she wants
ZEJULA has had a very successful year on the awards front. ZEJULA was recognized as a finalist in both the MM&M (Relationship Marketing) and PM360 Trailblazer Awards (Initiative | Persistence/Adherence). It also was nominated for the DTC National Advertising Awards. Those awards will announce their finalists list in late January.
The 10th annual Pharma Choice awards are the only one in the industry that allows everyone who works in the industry to have a say in who wins. All submissions for the awards are placed online where everyone can vote for their favorites based on content, format, imagination, influence on the industry, and overall quality. More than 7,000 votes total were cast to decide this year’s winners.
A Gold, Silver, and Bronze award is given to the top three vote-getters in each of the 14 distinct categories.